192 related articles for article (PubMed ID: 25474438)
1. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Ribas X; Costas M; Massaguer A; Planas M; Feliu L
Org Biomol Chem; 2015 Feb; 13(5):1470-80. PubMed ID: 25474438
[TBL] [Abstract][Full Text] [Related]
2. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M
Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538
[TBL] [Abstract][Full Text] [Related]
3. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
4. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides.
Soleymani-Goloujeh M; Nokhodchi A; Niazi M; Najafi-Hajivar S; Shahbazi-Mojarrad J; Zarghami N; Zakeri-Milani P; Mohammadi A; Karimi M; Valizadeh H
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):91-103. PubMed ID: 29258339
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific DNA cleavage by dipeptides disubstituted with chlorambucil and 2,6-dimethoxyhydroquinone-3-mercaptoacetic acid.
Minnock A; Lin LS; Morgan J; Crow SD; Waring MJ; Sheh L
Bioconjug Chem; 2001; 12(6):870-82. PubMed ID: 11716676
[TBL] [Abstract][Full Text] [Related]
7. Enthalpy-driven nuclease-like activity and mechanism of peptide-chlorambucil conjugates.
Yang RC; Huang JT; Chen YL; Hung CC; Liao M; Yao WC; Chen CH; Liou CC; Waring MJ; Sheh L
Org Biomol Chem; 2014 Jul; 12(27):4890-904. PubMed ID: 24874710
[TBL] [Abstract][Full Text] [Related]
8. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional peptide hybrids targeting the matrix of mitochondria.
Klimpel A; Neundorf I
J Control Release; 2018 Dec; 291():147-156. PubMed ID: 30367921
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide.
Gellerman G; Baskin S; Galia L; Gilad Y; Firer MA
Anticancer Drugs; 2013 Feb; 24(2):112-9. PubMed ID: 23187462
[TBL] [Abstract][Full Text] [Related]
13. Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems.
Kiss K; Biri-Kovács B; Szabó R; Ranđelović I; Enyedi KN; Schlosser G; Orosz Á; Kapuvári B; Tóvári J; Mező G
Eur J Med Chem; 2019 Aug; 176():105-116. PubMed ID: 31100648
[TBL] [Abstract][Full Text] [Related]
14. Lysosomally cleavable peptide-containing polymersomes modified with anti-EGFR antibody for systemic cancer chemotherapy.
Lee JS; Groothuis T; Cusan C; Mink D; Feijen J
Biomaterials; 2011 Dec; 32(34):9144-53. PubMed ID: 21872328
[TBL] [Abstract][Full Text] [Related]
15. Design of a tumor-homing cell-penetrating peptide.
Myrberg H; Zhang L; Mäe M; Langel U
Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Chlorambucil to the Brain Using Surface Modified Solid Lipid Nanoparticles.
Patra S; Dey J; Kar S; Chakraborty A
ACS Appl Bio Mater; 2024 May; 7(5):3403-3413. PubMed ID: 38700026
[TBL] [Abstract][Full Text] [Related]
17. Hyperbranched polyamidoamines containing beta-cyclodextrin for controlled release of chlorambucil.
Zhou Y; Guo Z; Zhang Y; Huang W; Zhou Y; Yan D
Macromol Biosci; 2009 Nov; 9(11):1090-7. PubMed ID: 19603385
[TBL] [Abstract][Full Text] [Related]
18. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
[TBL] [Abstract][Full Text] [Related]
19. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
20. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.
Lin R; Zhang P; Cheetham AG; Walston J; Abadir P; Cui H
Bioconjug Chem; 2015 Jan; 26(1):71-7. PubMed ID: 25547808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]